About
Small Molecule Generics
Areas of Focus
Categories
Generic DrugBrazilSouth America
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
24
As Collaborator
1
Total Enrollment
1,363
By Phase
PHASE2: 21PHASE3: 4
By Status
COMPLETED: 23TERMINATED: 2
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT02512653Lead Sponsor
Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
PHASE2Completed
33 participants
Started: Nov 30, 2015 · Completed: Jan 31, 2016
NCT02340130Lead Sponsor
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
PHASE2Completed
57 participants
Started: Sep 30, 2014 · Completed: Jun 30, 2018
NCT01984541Lead Sponsor
To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.
PHASE2Completed
30 participants
Started: Mar 31, 2014 · Completed: Sep 30, 2014
NCT01984528Lead Sponsor
To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.
PHASE2Completed
30 participants
Started: Feb 28, 2014 · Completed: Dec 31, 2014
NCT01821716Lead Sponsor
Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
PHASE2Completed
42 participants
Started: Mar 31, 2013 · Completed: Jan 31, 2014
Locations (1)
Headquarters
Anápolis, Brazil
Map
Loading map...